Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Doxorubicin × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 21 Burkitt Lymphoma 12 Breast Neoplasms 11 Neoplasms 10 Lymphoma, Follicular 10 Lymphoma 9 Triple Negative Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Sarcoma 7 Ovarian Neoplasms 6 Hodgkin Disease 6 Endometrial Neoplasms 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell 5 Sarcoma, Ewing 4 Recurrence 4 Osteosarcoma 4 Neuroblastoma 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Liposarcoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Fallopian Tube Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Biphenotypic, Acute 3 Leiomyosarcoma 3 Inflammatory Breast Neoplasms 3 Ganglioneuroblastoma 3 Urinary Bladder Neoplasms 2

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡